I treat menopause and its symptoms, and hormone replacement therapy can help – here’s the science behind the FDA’s decision to remove warnings

By: Genevieve Hofmann, University of Colorado Anschutz Medical Campus, The Conversation

Outlets: The Conversation

Published: November 18, 2025

Words: 1,396

Last Updated: 6 days, 21 hours ago

Body Text Preview

By Genevieve Hofmann, University of Colorado Anschutz Medical Campus

For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration describing the medication’s risk of serious harms – namely, cancer, cardiovascular disease and possibly dementia.

On Nov. 10, 2025, the FDA announced that drugmakers should remove these “black box” safety warnings.

The Conversation U.S. asked Genevieve Hofmann, a women’s health nurse practitioner at the University …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.
Register for Free Log in